If signs of hypersensitivity or skin irritation associated with the use of the drug are noted, discontinue treatment and consult a doctor. With prolonged treatment, when applying the drug on the vast surface of the skin, with the use of occlusive dressings,and also in children the systemic absorption of a glucocorticosteroid is possible; it is possible to suppress the function of the hypothalamic-pituitary-adrenal system and the development of symptoms of hypercorticism.
On the skin of the face more often than on other surfaces of the body, after prolonged treatment with local glucocorticosteroids, atrophic changes may appear; the course of treatment in this case should not exceed 5 days.
Care should be taken when applying the product to the face, wrinkles, the area of natural folds, to areas with thin skin.
Avoid contact with eyes. Do not apply the drug to mucous membranes. It should be borne in mind that glucocorticosteroids are capable of altering the manifestations of certain skin diseases, which can make diagnosis more difficult. In addition, the use of glucocorticosteroids may be the cause of delayed wound healing.
With prolonged therapy with glucocorticosteroids, sudden discontinuation of therapy can lead to the development of a bounce syndrome that manifests itself in the form of dermatitis with intense redness of the skin and a burning sensation. Therefore, after long-term treatment, the drug should be abolished gradually, for example, by switching to an intermittent treatment regimen before it is completely discontinued.Propyl parahydroxybenzoate, which is part of the drug, can cause allergic reactions (possibly delayed type). In such cases, the drug should be discontinued.
Pediatric Use
The drug can be used in children from 2 years. It should be borne in mind that in young children, skin folds, diapers, diapers can have an effect similar to the effect of an occlusive dressing, and increase systemic resorption glucocorticosteroid. In addition, children can have a greater degree of systemic resorption due to the relationship between skin surface and body weight, and also due to insufficient maturation of the skin. Long-term treatment of children with a glucocorticosteroid can lead to disruption of their growth and development. Therefore, long-term use of the drug should be carried out under the supervision of a doctor. Children should receive a minimum dose of the drug sufficient to achieve the effect. In children, the course of treatment should not exceed 7 days.